Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A single-center clinical trial protocol for a randomized, double-blind, placebo-controlled study evaluating Yiqi-Yangyin-Huoxue granules in patients with type 2 diabetes and early vascular aging. The trial, registered with the International Traditional Medicine Clinical Trial Registry, plans to enroll 120 participants between March 2025 and December 2026. The protocol describes primary and secondary outcomes, safety evaluations, and plans for metabolomic, proteomic, and metagenomic sequencing.
License is CC-BY-4.0, permitting sharing and adaptation with attribution. The file is a DOCX document, not a structured data file.